beta-lactams has been researched along with Skin Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chakkavittumrong, P; Chanprapaph, K; Chularojanamontri, L; Disphanurat, W; Klaewsongkram, J; Rerknimitr, P; Rerkpattanapipat, T; Srinoulprasert, Y; Srisuttiyakorn, C; Sukasem, C; Suthumchai, N; Thantiworasit, P; Tovanabutra, N; Tuchinda, P | 1 |
Broekhuizen, BD; Rockmann, H; Salden, OA; Verheij, TJ | 1 |
Gesser, RM; McCarroll, KA; Woods, GL | 1 |
Ceesay, TP; Gesser, R; Graham, DR; Holtom, P; Lucasti, C; Malafaia, O; McAdams, A; Nichols, RL; Perez, NQ; Woods, GL | 1 |
2 trial(s) available for beta-lactams and Skin Diseases
Article | Year |
---|---|
Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Female; Humans; Infusions, Intravenous; Lactams; Logistic Models; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Skin Diseases; Statistics, Nonparametric; Tazobactam; Treatment Outcome | 2004 |
Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Female; Humans; Lactams; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Skin Diseases; Staphylococcus aureus; Tazobactam; Treatment Outcome | 2002 |
2 other study(ies) available for beta-lactams and Skin Diseases
Article | Year |
---|---|
Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
Topics: Adult; Aged; Alleles; Allopurinol; Anticonvulsants; beta-Lactams; Cells, Cultured; Drug Hypersensitivity; Drug Hypersensitivity Syndrome; Drug-Related Side Effects and Adverse Reactions; Enzyme-Linked Immunospot Assay; Female; Genetic Association Studies; Genotype; HLA-B Antigens; Humans; Interferon-gamma; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Polymorphism, Genetic; Skin Diseases; Thailand | 2019 |
Diagnosis of allergy against beta-lactams in primary care: prevalence and diagnostic criteria.
Topics: Adolescent; Adult; Age Distribution; Anti-Bacterial Agents; Asthma; beta-Lactams; Child; Child, Preschool; Comorbidity; Diagnostic Errors; Drug Hypersensitivity; Electronic Health Records; Female; Humans; Immune System Diseases; Infant; Infant, Newborn; Male; Middle Aged; Netherlands; Prevalence; Primary Health Care; Registries; Retrospective Studies; Sex Distribution; Skin Diseases; Young Adult | 2015 |